Quinazoline derivatives as anticancer drugs: a patent review (2011 – present)

Expert Opinion on Therapeutic Patents - Tập 25 Số 7 - Trang 789-804 - 2015
Séverine Ravez1,2, Omar Castillo-Aguilera1,3,2, Patrick Depreux1,3,2, Laurence Goossens1,3,2
1+33 3 20 96 49 06
2Univ Lille, Institut de Chimie Pharmaceutique Albert Lespagnol 3 rue du Professeur Laguesse, B.P. 83, 59006 Lille, France +33 3 20 96 47 02
3UDSL, EA GRITA, F-59000 Lille, France

Tóm tắt

Từ khóa


Tài liệu tham khảo

Griess P, 1869, Berichte, 2, 415

Griess P, 1878, Berichte, 11, 1985

Bischler A, 1895, Chem Ber, 28, 279, 10.1002/cber.18950280169

Gabriel S, 1903, Chem Ber, 36, 3379, 10.1002/cber.190303603123

Wang D, 2013, Chem Cent J, 7, 95, 10.1186/1752-153X-7-95

Selvam TP, 2011, Res Pharm, 1, 1

Vijayakumar B, 2013, IJMCA, 3, 10

Coatney GR, 1950, J Natl Malar Soc, 9, 183

Fishman M, 1970, J Med Chem, 13, 155, 10.1021/jm00295a050

Zhu S, 2012, Bioorg Med Chem, 20, 927, 10.1016/j.bmc.2011.11.053

Marzaro G, 2012, Expert Opin Ther Pat, 22, 223, 10.1517/13543776.2012.665876

Bilbro J, 2013, Anticancer Res, 33, 4695

Van Horn KS, 2014, J Med Chem, 57, 3075, 10.1021/jm500039e

Lam T, 2014, J Med Chem, 57, 651, 10.1021/jm401204g

Singh B, 2013, Phytomedicine, 20, 441, 10.1016/j.phymed.2012.12.015

Hu J, 2014, ChemBiol Drug Des

Zhu S, 2012, Bioorg Med Chem, 20, 927, 10.1016/j.bmc.2011.11.053

Honkanen E, 1983, J Med Chem, 26, 1433, 10.1021/jm00364a014

Capra M, 2006, Cancer Res, 66, 8147, 10.1158/0008-5472.CAN-05-3489

Holderfield M, 2014, Nat Rev Cancer, 14, 455, 10.1038/nrc3760

Wilhelm S, 2006, Nat Rev Drug Discov, 5, 835, 10.1038/nrd2130

Davies H, 2002, Nature, 417, 949, 10.1038/nature00766

10.1016/j.ejmech.2013.11.018

Hemmings BA, 2012, Cold Spring Harb Perspect Biol, 4, a011189, 10.1101/cshperspect.a011189

Fruman DA, 2014, Nat Rev Drug Discov, 13, 140, 10.1038/nrd4204

Welker ME, 2013, Bioorg Med Chem, 21, 4063, 10.1016/j.bmc.2013.04.083

Goldenson B, 2015, Oncogene, 34, 537, 10.1038/onc.2014.14

Mortlock AA, 2007, J Med Chem, 50, 2213, 10.1021/jm061335f

10.1634/theoncologist.8-6-531

Lemmon MA, 2010, Cell, 141, 1117, 10.1016/j.cell.2010.06.011

Arora A, 2005, J Pharmacol Exp Ther, 315, 971, 10.1124/jpet.105.084145

Denny WA, 2001, Farmaco, 56, 51, 10.1016/S0014-827X(01)01026-6

Ocaña A, 2013, CurrPharm Des, 19, 808

Roskoski R, 2014, Pharmacol Res, 79, 34, 10.1016/j.phrs.2013.11.002

Carmi C, 2011, Mini Rev Med Chem, 11, 1019, 10.2174/138955711797247725

Carmi C, 2012, Biochem Pharmacol, 84, 1388, 10.1016/j.bcp.2012.07.031

10.1016/j.critrevonc.2011.11.010

Shibuya M, 2011, Genes Cancer, 2, 1097, 10.1177/1947601911423031

Tie J, 2012, Crit Rev Oncog, 17, 51, 10.1615/CritRevOncog.v17.i1.50

Tugues S, 2011, Mol Aspects Med, 32, 88, 10.1016/j.mam.2011.04.004

Rogosin S, 2012, Clin Lung Cancer, 13, 326, 10.1016/j.cllc.2011.12.001

10.1016/j.ejmech.2013.06.055

Marvania B, 2011, Bioorg Med Chem, 19, 1987, 10.1016/j.bmc.2011.01.055

Barneda-Zahonero B, 2012, Mol Oncol, 6, 579, 10.1016/j.molonc.2012.07.003

West AC, 2014, J Clin Invest, 124, 30, 10.1172/JCI69738

Meitzler JL, 2014, Antioxid Redox Signal, 20, 2873, 10.1089/ars.2013.5603

Wang X, 2014, Int J Oncol, 45, 18, 10.3892/ijo.2014.2399